Abstract |
Since HIV requires CD4 and a co-receptor, most commonly C-C chemokine receptor 5 (CCR5), for cellular entry, targeting CCR5 expression is an attractive approach for therapy of HIV infection. Treatment of CD4(+) T cells with zinc-finger protein nucleases (ZFNs) specifically disrupting chemokine receptor CCR5 coding sequences induces resistance to HIV infection in vitro and in vivo. A chimeric Ad5/F35 adenoviral vector encoding CCR5-ZFNs permitted efficient delivery and transient expression following anti-CD3/anti-CD28 costimulation of T lymphocytes. We present data showing CD3/CD28 costimulation substantially improved transduction efficiency over reported methods for Ad5/F35 transduction of T lymphocytes. Modifications to the laboratory scale process, incorporating clinically compatible reagents and methods, resulted in a robust ex vivo manufacturing process capable of generating >10(10) CCR5 gene-edited CD4+ T cells from healthy and HIV+ donors. CD4+ T-cell phenotype, cytokine production, and repertoire were comparable between ZFN-modified and control cells. Following consultation with regulatory authorities, we conducted in vivo toxicity studies that showed no detectable ZFN-specific toxicity or T-cell transformation. Based on these findings, we initiated a clinical trial testing the safety and feasibility of CCR5 gene-edited CD4+ T-cell transfer in study subjects with HIV-1 infection.
|
Authors | Dawn A Maier, Andrea L Brennan, Shuguang Jiang, Gwendolyn K Binder-Scholl, Gary Lee, Gabriela Plesa, Zhaohui Zheng, Julio Cotte, Carmine Carpenito, Travis Wood, S Kaye Spratt, Dale Ando, Philip Gregory, Michael C Holmes, Elena E Perez, James L Riley, Richard G Carroll, Carl H June, Bruce L Levine |
Journal | Human gene therapy
(Hum Gene Ther)
Vol. 24
Issue 3
Pg. 245-58
(Mar 2013)
ISSN: 1557-7422 [Electronic] United States |
PMID | 23360514
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- CD28 Antigens
- CD3 Complex
- Receptors, CCR5
- DNA Restriction Enzymes
|
Topics |
- Adenoviruses, Human
(genetics)
- Adoptive Transfer
- Animals
- CD28 Antigens
(immunology)
- CD3 Complex
(immunology)
- DNA Restriction Enzymes
(genetics, metabolism)
- Female
- Genetic Vectors
(administration & dosage, adverse effects, genetics, standards)
- HIV Infections
(genetics, immunology, therapy)
- Humans
- Lymphocyte Activation
(immunology)
- Male
- Mice
- Phenotype
- Receptors, CCR5
(genetics, immunology)
- T-Lymphocytes
(immunology, metabolism)
- Transduction, Genetic
(methods, standards)
- Transplantation, Heterologous
- Zinc Fingers
(genetics)
|